John Nano, Chairman & CEO of Competitive Technologies, explains their new breakthrough pain management system.

The therapy device, from the research of CTT client Professor Giuseppe Marineo of Delta Research & Development in Rome, treats oncological and neuropathic pain that has proven resistant to traditional drug protocols.

The non-invasive treatment from the research of CTT client Professor Marineo has already been used with successful results in seven hospitals in Italy on over 2,000 patients suffering from intense drug-resistant pain. The device has received Medical Device CE certification from the European Union as an approved electronic-analgesic apparatus. The treatment is performed by applying surface electrodes to the skin to simultaneously treat multiple pain areas.